Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05292521 · ClinicalTrials.gov registry record · NA

Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer

A NA study of Lung Non-Small Cell Carcinoma and Stage II Lung Cancer AJCC v8, sponsored by Roswell Park Cancer Institute.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT05292521 is a NA study of Lung Non-Small Cell Carcinoma and Stage II Lung Cancer AJCC v8 that is actively recruiting participants, run by Roswell Park Cancer Institute. The registered enrollment target is 150 participants, roughly in line with the 157-participant average among 47 other Lung Non-Small Cell Carcinoma trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05292521, a NA study of Lung Non-Small Cell Carcinoma and Stage II Lung Cancer AJCC v8, is actively recruiting participants, sponsored by Roswell Park Cancer Institute.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

This clinical trial studies the effect of a quality of life intervention on decision-making in patients with early-stage lung cancer who are undergoing standard of care surgery or stereotactic body radiation therapy (SBRT). Providing quality of life outcome data to patients deciding between surgery and SBRT may help decrease decision regret and increase patient satisfaction with their care.

Interventions

  • OTHER Questionnaire Administration
  • OTHER Best Practice
  • OTHER Informational Intervention

Study Locations (1)

New York

  • Roswell Park Cancer Institute - Buffalo

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2023-12-21
Est. Completion 2028-12-21
Phase NA

Sponsor

Roswell Park Cancer Institute

365 total trials

What the Registry Record Tells You About NCT05292521

The ClinicalTrials.gov registry entry for NCT05292521 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 157-participant average among 47 other Lung Non-Small Cell Carcinoma trials with a reported enrollment target. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Lung Non-Small Cell Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.

NCT05292521 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05292521 about?

NCT05292521 is a clinical study titled "Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer". This clinical trial studies the effect of a quality of life intervention on decision-making in patients with early-stage lung cancer who are undergoing standard of care surgery or stereotactic body radiation therapy (SBRT). Providing quality of life outcome data to patients deciding between surgery ...

What is the current status of trial NCT05292521?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-12-21. Estimated completion is 2028-12-21.

What conditions does trial NCT05292521 study?

This clinical trial studies the following conditions: Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage I Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8, Stage IIB Lung Cancer AJCC v8.

What interventions are being tested in trial NCT05292521?

The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER), Informational Intervention (OTHER).

Who is sponsoring clinical trial NCT05292521?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05292521 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Non-Small Cell Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.